Flowserve heads into its Q1 results — released after the bell on April 29 — having attracted a sharp and unusual buildup of short interest, even as options traders leaned bullish and the stock sat near multi-month highs.
The short side of the ledger tells a striking story. Short interest climbed 65% over the past month to roughly 4.4% of the float, and jumped another 25% in the single week before the print. That is not a trivial move for a mid-sized industrial — it represents a near-doubling of the short position from mid-March levels around 2.7%, with the sharpest acceleration hitting in the final days before the result. The ORTEX short score edged up to 39.6, its highest reading of the past two weeks, reflecting the pace and direction of that positioning shift. What makes the setup more interesting is that borrowing costs are not flashing distress: the cost to borrow has actually eased to 0.41% — roughly 14% cheaper than a week earlier — which suggests new shorts faced no meaningful friction entering the position. Availability has tightened in parallel, though, with utilization climbing to 7.79% from under 3% as recently as mid-April. The borrow market is tighter than it was, but not yet squeezed.
Options positioning told the opposite story going into the release. The put/call ratio fell to 0.44 on April 29, well below its 20-day average of 0.57 — the most call-skewed reading in several weeks. That divergence is notable: while short sellers were adding exposure at pace, options traders were rotating toward upside. Peers offered limited reassurance on the day; fell 1.3% and dropped 1.5% on Wednesday while dipped just under 1%, holding up relatively well in a broadly soft session for industrials.
The Street remained broadly constructive ahead of the print. Analyst consensus is bullish, with the mean price target at $96.10 — roughly 14% above the $84.25 close. The most recent analyst action came from Stifel on April 14, raising its target to $102 while keeping a Buy rating, after Citigroup made a token $1 trim to $97 the day prior while holding Buy. The bull case centers on a sharp margin expansion story — adjusted operating margins widening 370 basis points year-on-year to 14.8% — and strength in nuclear and power infrastructure bookings. Bears point to the sales growth trajectory, with organic sales guidance trimmed to 1-3% growth, and argue the stock trades at a discount to SMID-cap peers that may not fully close without a more convincing top-line recovery. The P/E has re-rated meaningfully, adding over 2.4 points in the past 30 days to nearly 19.6x, which underscores how much of the bull thesis the market has already been pricing in.
The actual Q1 result delivered a split verdict. Flowserve beat on adjusted EPS — $0.85 versus the $0.80 estimate — but sales of $1.068 billion badly missed the $1.168 billion consensus. The company held its full-year adjusted EPS guidance of $4.00-$4.20 but cut the revenue range, trimming the top end to $5.013 billion from $5.060 billion. That combination — earnings resilience with a top-line miss and a guide-down on sales — is the classic setup where the near-term stock reaction depends almost entirely on how the market weights margin quality against revenue disappointment. The previous quarterly print in late February produced a one-day decline of 4.2%, the only comparable earnings reaction in the recent data.
With the result now out, the focus shifts to how those newly added short positions respond and whether the call-skewed options flow from the past week gets rewarded or rapidly unwound. The size of the pre-earnings short buildup, set against a retained EPS guide and a tightening borrow market, makes the post-print positioning adjustment the next key thing to watch.
See the live data behind this article on ORTEX.
Open FLS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
